Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 782

Cala Health holds on to $50m

Alphabet, Novartis and Johnson & Johnson have contributed to a series C round for Cala Health, which is preparing to release its wearable hand-tremor treatment device.

May 22, 2019

Sun Basket orders $30m in fresh funding

Unilever Ventures participated in a series E round that increased the healthy meal delivery service's overall funding to $125m.

May 22, 2019

Holodeck VR stations ProSiebenSat.1

Free-roam VR experience technology company Holodeck VR has been backed by ProSiebenSat.1 Media, raising the prospect of business development collaborations with the corporate's television networks.

May 22, 2019

Upswing sizes up $2m

Stanford-backed student support platform UpSwing has added $2m from investors including Impact America Fund to take its total to approximately $5m.

May 22, 2019

Robin lands on $20m for series B

Allegion's corporate venturing arm has taken part in a $20m round for the office management software provider, whose early backers include Autodesk and Konica Minolta.

May 22, 2019

SIG helps Shanzhen take care of funding

Susquehanna International Group has led a series B round for elderly healthcare services provider Shanzhen that was in the eight-figure dollar range.

May 22, 2019

Unit DX marks $25.5m in portfolio funding

Members of science incubator Unit DX have obtained $25.5m of capital altogether since launch in 2017, with many of its residents hailing from University of Bristol.

May 21, 2019

Schrödinger boxes up $110m

The drug development software provider has added $25m to an Alphabet and Wuxi AppTech-backed first tranche it closed in January.

May 21, 2019

Auth0 logs into $103m series E

Telstra and NTT Docomo-backed dentity management platform developer Auth0 is now valued at more than $1bn after closing its latest round.

May 21, 2019

Reneo generates $50m in series A round

Lundbeckfond Ventures contributed to a round that will fund clinical trials for Reneo Pharmaceuticals' mitochondrial disease therapies.

May 21, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here